SKOLNICK PHIL (Chief Scientific Officer) sold 1.6% of their position (369.00 shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $7.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/9/2023ACC: 0001385508-23-000020
Officer· Chief Scientific Officer
Since Oct 2018
-369.00
Net shares
Net seller
$7.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
369.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−369.00
Price / share
$20.20
Trade value
$7.45K
% of position
1.6%
1/9/2023
22.40K→22.03K
Total
Net shares
−369.00
Net value
-$7.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2023 | S · Sale | −369.00 | $20.20 | $7.45K | 1.6% | 22.40K | 22.03K |
| Total | −369.00 | -$7.45K | ||||||
Derivative Transactions0
No derivative transactions reported